Moors & Cabot, Inc. Bausch Health Companies Inc. Transaction History

Moors & Cabot, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$25.04 - $30.06 $249,523 - $299,547	-9,965 Reduced 83.04%	2,035 $228,000
Q1 2019 May 01, 2019	BUY	$20.23 - $26.29 $242,760 - $315,480	12,000 New	12,000 $292,000
Q4 2018 Feb 13, 2019	SELL	$17.64 - $28.32 $168,462 - $270,456	-9,550 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $197,112 - $245,148	9,550 New	9,550 $246,000

271

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.59B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.